Cargando…
Leukemia Inhibitory Factor: An Important Cytokine in Pathologies and Cancer
Leukemia Inhibitory Factor (LIF) is a member of the IL-6 cytokine family and is expressed in almost every tissue type within the body. Although LIF was named for its ability to induce differentiation of myeloid leukemia cells, studies of LIF in additional diseases and solid tumor types have shown th...
Autores principales: | Jorgensen, Megan M., de la Puente, Pilar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961628/ https://www.ncbi.nlm.nih.gov/pubmed/35204717 http://dx.doi.org/10.3390/biom12020217 |
Ejemplares similares
-
Role of leukemia inhibitory factor in nasopharyngeal carcinogenesis
por: Liu, Shu-Chen, et al.
Publicado: (2014) -
The Molecular Basis and Therapeutic Potential of Leukemia Inhibitory Factor in Cancer Cachexia
por: Zeng, Ruijiang, et al.
Publicado: (2022) -
Leukemia Inhibitory Factor: A Potential Biomarker and Therapeutic Target in Pancreatic Cancer
por: Wrona, Ewa, et al.
Publicado: (2021) -
Interactions between Autophagy and Inhibitory Cytokines
por: Wu, Tian-tian, et al.
Publicado: (2016) -
Human Plasma-Derived 3D Cultures Model Breast Cancer Treatment Responses and Predict Clinically Effective Drug Treatment Concentrations
por: Calar, Kristin, et al.
Publicado: (2020)